Response of glioblastomas to EGFR kinase inhibitors - Letter to the editor Journal Article

  

Authors:	Lassman, A. B.; Abrey, L. E.; Gilbert, M. R.
Article Title:	Response of glioblastomas to EGFR kinase inhibitors - Letter to the editor
Keywords:	signal transduction; protein expression; gene deletion; erlotinib; validation process; outcome assessment; letter; sensitivity analysis; epidermal growth factor receptor; analytic method; receptor, epidermal growth factor; phosphorylation; biopsy; protein kinase inhibitors; glioblastoma; drug response; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; pten phosphohydrolase; gefitinib; tumor suppressor protein; quinazolines; treatment withdrawal; epidermal growth factor receptor kinase inhibitor
Journal Title:	New England Journal of Medicine
Volume:	354
Issue:	5
ISSN:	0028-4793
Publisher:	Massachusetts Medical Society
Date Published:	2006-02-02
Start Page:	525
End Page:	526
Language:	English
DOI:	10.1056/NEJMc053459
PUBMED:	16452568
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-32044436718&partnerID=40&md5=3a5e3761cedb1707b57b884e447e4faf
Notes:	--- - "Cited By (since 1996): 14" - "Export Date: 4 June 2012" - "CODEN: NEJMA" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/27587